Pierre Chelle

10PUBLICATIONS
25CO-AUTHORS
Pharmaceutical delivery technologiesEpidemiological methodsHaematologyHaematological tumoursNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 24, 2025
An Open-Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design.

Abdullah Hamadeh, Moriah Pellowe, Pierre Chelle

|May 10, 2025
A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A.

Dagmar M Hajducek, Oceana Sinkovic, Pierre Chelle

|Mar 07, 2025
Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling.

Pierre Chelle, Dagmar Hajducek, Emma Iserman

|May 13, 2024
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi-country severe WAPPS-Hemo haemophilia patients.

Dagmar M Hajducek, Pierre Chelle, Alfonso Iorio

|May 03, 2024
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS-Hemo platform.

Pierre Chelle, Dagmar Hajducek, Karen Thibaudeau

|Feb 21, 2024
Canadian clinical experience on switching from standard half-life recombinant factor VIII (rFVIII), octocog alfa, to extended half-life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada.

Davide Matino, Federico Germini, Anthony K C Chan

Pageof 2

Frequent Collaborators

9 joint publications

Andrea N Edginton

7 joint publications

Alfonso Iorio

1 joint publications

Anthony Mutsaers

1 joint publications

Shawn Wettig